In 2023, Janumet and its extended-release version generated approximately $1.43 billion in combined sales. Like Januvia, these products face patent expiry that will open the door to generic equivalents, triggering rapid price erosion and a sharp decline in revenue. Annual Sales of Januvia reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies. Januvia Market Analysis, Sales Projections, Patent Expiration, and Generic Entry Risk What is Januvia and how does it compete in type 2 diabetes? Januvia is Merck's branded sitagliptin product, an oral dipeptidyl peptidase-4, or DPP-4, inhibitor approved for adults with type 2 diabetes. It is available primarily as 25 mg, 50 mg, and 100 mg tablets. Over the past eleven years, Januvia (sitagliptin) has demonstrated a strong and sustained contribution to the global type 2 diabetes market, remaining one of Merck's key revenue-generating brands for much of the last decade. From the mid-2010s, Januvia's annual revenues steadily increased, reflecting broad physician adoption, a favourable safety profile, and its established position as a … Pharmaceutical sales growth in 2023 was partially offset by lower sales of the COVID-19 medication LAGEVRIO, as well as lower sales of JANUVIA and JANUMET, primarily reflecting generic competition in many ex-U.S. markets and lower demand in the U.S., and lower sales of PNEUMOVAX 23 as the market continues to shift toward newer adult … Januvia sales were $487 million in the quarter, down 38% primarily due to lower pricing in the U.S., as well as ongoing generic competition in many international markets. Pharmaceutical sales growth in 2024 was partially offset by lower sales of JANUVIA and JANUMET, primarily reflecting lower pricing in the U.S. and generic competition in many international markets, lower sales of the COVID-19 medication LAGEVRIO, lower sales of GARDASIL/GARDASIL 9 and lower sales of SIMPONI and REMICADE, reflecting the transfer … Januvia was a $6 billion franchise for a decade. Generics launch in May 2026, but revenue is already down 64% from peak – squeezed by GLP-1 competition from above and generic anticipation from below. The antidiabetic Januvia/Janumet (sitagliptin) saw a 12% increase in sales. MSD's revenue in China declined by 66% to USD 1.816 billion, primarily due to lower demand for its Gardasil HPV vaccine franchise, which saw a 39% global sales decline to USD 5.2 billion. Combined Januvia and Janumet sales were approximately $5.6 billion in 2023, making the franchise material to Merck's pharmaceutical revenue base. [1] Janumet alone represents approximately one-fifth of the combined Januvia franchise. Its decline has three financial effects: Lower branded diabetes revenue. Compare prices and print coupons for Januvia and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $44.18 Merck & Co's first quarter net income has more than tripled thanks to lower charges and a striking rise in sales of its diabetes drugs Januvia and Janumet. Transfer your prescription for JANUVIA 25 MG TAB on Amazon Pharmacy. FREE SHIPPING for Prime members. Offsetting Merck's growth in the third quarter were disappointing revenues from its HPV vaccine Gardasil and type 2 diabetes pill Januvia, with the company on Thursday narrowing its 2024 sales and adjusted profit outlooks. Compare Januvia prices, print discount coupons, find manufacturer promotions, copay cards and patient assistance programs. Compare Januvia 100 mg prices from verified online pharmacies or local U.S. pharmacies. Free coupons for Januvia. Discounts up to 80% off the retail price. JANUVIA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: JANUVIA should not be used in patients with type 1 diabetes ( 1 ) JANUVIA has not been studied in patients with a history of pancreatitis. ( 1 , 5.1 ) Compare generic Januvia (sitagliptin phosphate) 25 mg prices from verified online pharmacies or local U.S. pharmacies. Free coupons for generic Januvia (sitagliptin phosphate). Discounts up to 80% off the retail price. Get the best price on Januvia at pharmacies near you with SingleCare. Save up to 80% with our Januvia coupons – with or without insurance! Januvia remains the most prescribed DPP-4 inhibitor worldwide, with consistent sales driven by its favorable safety profile and prescription habits. What Factors Influence Januvia's Market Dynamics? A 1-month supply of Januvia can cost hundreds of dollars without insurance. Save with alternatives, coupons, discount cards, and more. Januvia is prescribed to treat type 2 diabetes. Learn more and get brand name and generic Januvia prices cheap online at this certified online pharmacy. Merck's experience with Januvia and Janumet in international markets shows why brand-name drugmakers want to protect their patents. After regulators overseas approved generic versions of the drugs last year, worldwide combined sales of Januvia and Janumet declined from $3.6 billion to $2.6 billion, or 28%, in the first nine months of 2023. Aggressive marketing of Merck & Co.'s new first-in-class diabetes drug Januvia has led to a strong launch, according to data compiled by ImpactRx Inc., a market research company that tracked … Transfer your prescription for JANUVIA 100 MG TAB on Amazon Pharmacy. FREE SHIPPING for Prime members. Get your Januvia (Sitagliptin) 50mg Tablets from HealthWarehouse, your trusted online pharmacy. We offer affordable healthcare products that get delivered right to your door. Compare Sitagliptin Phosphate prices at 60,000+ US pharmacies. Get a free Rx.com coupon and save up to 90% on your prescription. Get Januvia for just $80/month through the Patient Assistance Program. Affordable savings without coupons for patients managing type 2 diabetes. Find the lowest prices for Januvia at pharmacies near you. Get free RxSaver coupons and save up to 80% on your prescription. Merck spooked investors on Thursday with a guidance cut after sales of its diabetes drugs and HPV vaccine lagged third-quarter forecasts. Merck & Co Inc reported lower sales of its Januvia diabetes treatment, fresh evidence its biggest product is losing ground to newer drugs, and also spooked investors with falling quarterly sales … Sitagliptin Phosphate or Januvia Savings, Coupons and Information. | SITAGLIPTIN (sit a GLIP tin) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). Global sales of Januvia, Merck's inhibitor for the treatment of type 2 diabetes, increased from $2.39 billion in 2010 to $3.7 billion in 2017. However, the sales declined by 4% in 2017 due to … Merck's monopoly on a blockbuster diabetes drug that has generated about $50 billion in global sales seemed like it might be coming to an end over the past couple years. The pharmaceutical giant's key U.S. intellectual property on the active ingredient in Januvia was set to expire in early 2023 … Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates, saying the imminent loss of exclusivity on diabetes drug Januvia and other legacy medicines will impact more than … Transfer your prescription for JANUVIA 50 MG TAB on Amazon Pharmacy. FREE SHIPPING for Prime members. Pharmaceutical sales growth in 2022 was partially offset by lower sales of JANUVIA and JANUMET, primarily reflecting lower demand in Europe as a result of generic competition, and a decline in PNEUMOVAX 23 sales as the U.S. market continues to shift toward newer adult pneumococcal conjugate vaccines. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics, reflecting the state of diabetes treatment. Januvia: once daily treatment for type-2 diabetes. Tailored aftercare. Consult an expert online. Free express delivery. US pharmacy. Januvia and Janumet are Merck & Co.'s (MRK) blockbuster diabetes drugs. They're are used to lower blood sugar levels in patients with Type 2 diabetes.